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Abstract:  Tako-tsubo cardiomyopathy (transient left ventricular apical ballooning) is a reversible form of 
cardiomyopathy of unknown etiology. Tako-tsubo Cardiomyopathy (TTC) is typically precipitated by sudden 
emotional or physical stress, and is associated with excessive sympathetic stimulation and catecholamine 
release. Its clinical presentation is similar to that of acute coronary syndrome. The diagnosis of TTC must be 
considered in all patients who develop a transient left ventricular apical (or mid ventricular) ballooning in the 
absence of obstructive coronary artery disease. Although the prevalence of TTC remains unknown, 
approximately 2% of all patients presenting with a presumed diagnosis of acute myocardial infarction have 
been found to have this syndrome. An illustrative case report and literature review is provided. 
Key Words: : Tako-tsubo cardiomyopathy; stress cardiomyopathy; left ventricular apical ballooning; cardiomyopathy. 
Case presentation 
A 72-year old woman presented with a two hour 
history of chest pain and mild respiratory distress. 
She reported a dull ache across the anterior chest 
unrelated to exertion, with some radiation to the 
left shoulder. She had no significant past medical 
history and no prior history of similar chest pain.  
She denied any history of recent emotional or 
physical stress. 
Physical examination revealed a heart rate of 
76, blood pressure 130/65 mmHg, and a 
respiratory rate of 20/minute. Cardiovascular 
examination revealed normal jugular venous 
pressure, soft heart sounds, no gallop rhythm, and 
no murmur. Lung sounds were clear throughout 
with no adventitious sounds. The 12-lead 
electrocardiogram showed minor ST-segment 
elevation and inverted T-waves in leads V3-V6. 
Serum creatinine phosphokinase was elevated at 
330 U/L (normal range: 45-130 U/L) and serum 
Troponin I at 3.6 (normal < 0.01).  Chest-X-ray 
was unremarkable. Coronary angiogram on 
admission showed no significant coronary artery 
disease. Left ventriculogram revealed apical 
dyskinesis and basal hyperkinesis, a picture 
consistent with TTC (Figure 1). She had no further 
recurrence of chest pain and her hospital course 
was unremarkable. She was discharged on 
metoprolol 25 mg twice a day, ramipril 5 mg daily, 
and warfarin. A repeated cardiac catheterization 
three months later revealed normal left ventricle 
function with complete resolution of apical 
dyskinesis (figure 2). 
 
Discussion  
Tako-tsubo cardiomyopathy is a potentially life-
threatening cardiac syndrome characterized by 
transient left ventricular dysfunction, without 
angiographically significant coronary artery 
stenosis. The disease takes its name from the 
typical left apical ballooning observed on end 
systolic left ventriculogram, which has the 
appearance of a Tako-Tsubo, a term for an 
ancient device used in Japan to trap octopuses in 
the sea. Other names, stress cardiomyopathy, 
tako-tsubo cardiomyopathy, left ventricular apical 
ballooning syndrome, and broken heart syndrome 
are used interchangeably. 
It is estimated that about 2% of patients 
presenting with suspected acute coronary 
syndromes may actually have TTC [1]. Although 
initially reported only in Japan, it has been 
reported in patients with diverse ethnic 
background from all over the world [2-6].  
 
The clinical presentation is identical to that of 
acute coronary syndromes. The most frequent 
presentation is chest pain (66%), followed by 
dyspnea (16%) [4]. Most patients have no prior 
cardiac history. The trigger factor is an emotional 
or physical stressor in 70% of cases [7]. 
Several mechanisms have been proposed to 
explain the underlying pathophysiology of this 
syndrome. These include an acute and excessive 
rise of catecholamine levels, calcium overload with 
direct myocyte damage, estrogen depletion, 
multiple vessel epicardial  coronary spasm or 
diffuse microvascular spasm [8-10]. Increased 
sympathetic tone with elevated levels of plasma 
catecholamines and stress neuropeptides may 
play an important role in the pathogenesis of 
myocardial stunning following emotional and 
physical stress [6]. 
Reduction of estrogen levels may explain the 
high incidence of TTC in postmenopausal females 
[8].  
 
Diagnosis 
Electrocardiography (ECG) can be normal, or 
can have nonspecific ST- and T-wave 
abnormalities. The most common ECG 
abnormality (in 70% of cases) is ST-segment 
elevation in the anterior precordial leads [4, 11]. 
There is less inferior reciprocal ST-depression 
than is typically seen with an anterior ST-segment 
elevation myocardial infarction [11]. Ten percent of 
patients develop Q-waves (most frequently in 
leads V2-V4). Within 24 to 48 hours of the acute 
presentation, the ECG frequently shows deeply 
inverted T-waves and a markedly prolonged QT-
interval in both precordial and limb leads. The QT-
interval prolongation  often normalizes within two 
days, but the T-wave abnormalities can take 
weeks or even months to normalize [6,11].  
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Most patients with TTC have mildly elevated 
cardiac enzymes (including creatine 
phosphokinase, Troponin I, and T levels) at the 
time of presentation. These enzyme elevations, 
however, are much lower than those typically 
observed with acute myocardial infarction [4, 6].  
Perhaps the most specific diagnostic feature of 
this syndrome is the unusual left ventricular 
contractile pattern in the absence of significant 
coronary artery disease. The left ventriculogram 
frequently shows akinesis or dyskinesis of the 
apical and midventricular segments with 
hyperkinesis of the basal segments (Figure 1).  
 
Treatment 
The treatment of TTC is generally supportive in 
nature. The standard supportive
  care for 
congestive heart failure with diuretics and 
vasodilators
  remains largely empirical. For 
hemodynamically stable patients, diuretics are 
used to treat pulmonary congestion, and 
Angiotensin-converting enzyme (ACE) inhibitors 
and beta-blockers are frequently used during the 
period of LV recovery. Beta-adrenergic blockers 
are also useful in suppressing ventricular 
arrhythmia. There is no consensus on how long to 
continue these medications; it is probably safe to 
stop them once LV function has completely 
recovered.     
                                                     
Figure 1 (A) Left ventriculogram in diastole. (B) Left 
ventriculogram in systole showing apical dyskinesis 
(ballooning) and basal hyperkinesis. 
 
 
Figure 2 (A) Left ventriculogram in diastole. (B) Left 
ventriculogram in systole showing normal systolic 
function and complete resolution of apical dyskinesis 
(ballooning). 
Unless there is a contraindication, systemic 
anticoagulation should also be considered during 
the first few days until apical contractility recovers. 
For hemodynamically unstable patients, the 
treatment includes inotropic therapy, vasopressor 
support, and intra-aortic balloon counterpulsation. 
Recent data implicate massive
  catecholamine 
release as the pathogenesis of stress-induced 
myocardial  stunning. Therefore, it has been 
recommended to avoid the administration of 
exogenous catecholamines and beta-agonists 
whenever possible and to rely on mechanical 
circulatory support, e.g., intra-aortic balloon 
counterpulsation [6]. Whichever form of 
hemodynamic support is chosen, most patients 
only require it for a short time and typically 
demonstrate rapid clinical recovery.  
 
Prognosis 
In most patients, the left ventricular function 
returns to normal within two weeks. The ECG 
abnormalities usually disappear completely within 
six months [12]. Complications like shock, 
followed by heart failure, LV thrombus formation, 
dynamic LV outflow tract obstruction, acute mitral 
valve regurgitation,  and ventricular arrhythmias 
are seen in 18% of cases (13, 14). The in-hospital 
mortality rate is 1.1%. Interestingly, physical stress 
has higher mortality rates when compared to 
patients presenting with emotional stress [8]. 
Recurrence rate is only 3.5% [5]. 
 
Conclusion 
Tako-tsubo cardiomyopathy (TTC) is an 
increasingly recognized diagnosis. Its clinical 
presentation mimics the presentation of acute ST- 
elevation myocardial infarction without 
concomitant epicardial coronary artery disease. 
Despite the initial dramatic presentation of this 
disease the prognosis is quite favourable.  
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